Data2Life

Company Overview

Snapshot

Founded in February 2014 by Itzik Lichtenfeld and Limor BH Epstein, Data2Life operated with 1–10 employees. The company raised $4.3 million across one funding round, developing solutions for patient-centered real-world evidence analytics.

Business overview

Data2Life develops B2B solutions that provide easy access to patient-centered real-world evidence (RWE) analytics. The company's core technology leverages artificial intelligence, including proprietary deep-learning algorithms, to distill and analyze patient-generated data alongside traditional datasets. This powers a drug intelligence platform that delivers holistic RWE, precise and personalized patient profiles, and predictive trends for therapeutic journeys. Data2Life serves markets within the Health Tech & Life Sciences sector, focusing on healthcare providers, hospitals, insurance companies, and pharmaceutical firms, with applications in drug development and medical cannabis.

Strategic signal

In June 2019, Data2Life announced that its AI-powered Real-World Evidence (RWE) platform was supporting the CannaPharma industry's growth, particularly in response to FDA concerns. This signals the company's strategic focus on applying its advanced analytics to emerging and regulated sectors, demonstrating its platform's adaptability and relevance in addressing complex industry challenges and regulatory landscapes.

Company Intelligence Q&A

What is Data2Life's primary focus?

Data2Life focuses on developing solutions for patient-centered real-world evidence (RWE) analytics, integrating patient-generated data with traditional datasets to provide comprehensive health intelligence.

When did Data2Life cease operations?

Data2Life ceased to operate in January 2020.

What was a key application of Data2Life's AI platform in June 2019?

In June 2019, Data2Life's AI-powered RWE platform was highlighted for its support of the CannaPharma industry, addressing FDA concerns and facilitating advancements in the sector.

What was the total capital raised by Data2Life?

Data2Life raised a total of $4.3 million across one funding round.

What was the focus of The Sage Group's announcement in September 2018?

In September 2018, The Sage Group announced Sage Real World Intelligence (Sage RWI), a resource for product and market assessment, which was related to Data2Life's work in real-world evidence.